Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

Peer Review reports

Original Submission
18 Sep 2019	Submitted	Original manuscript
16 Dec 2019	Reviewed	Reviewer Report - Chin Kook Rhee
27 Dec 2019	Reviewed	Reviewer Report - Anant Mohan
20 Jan 2020	Author responded	Author comments - Dirk Slebos
Resubmission - Version 2
20 Jan 2020	Submitted	Manuscript version 2
Publishing
23 Jan 2020	Editorially accepted
13 Feb 2020	Article published	10.1186/s12890-020-1058-5

Back to article page